Solid Biosciences Shares Are Trading Higher After Piper Sandler Upgraded the Stock From Neutral to Overweight and Raised Its Price Target From $8 to $20
在派珀·桑德勒將股票從中性上調至增持並將其目標股價從8美元上調至20美元之後,Solid Biosciences的股價走高
Solid Biosciences Shares Are Trading Higher After Piper Sandler Upgraded the Stock From Neutral to Overweight and Raised Its Price Target From $8 to $20
在派珀·桑德勒將股票從中性上調至增持並將其目標股價從8美元上調至20美元之後,Solid Biosciences的股價走高
使用瀏覽器的分享功能,分享給你的好友吧